View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
June 28, 2019

California: Hub for biotech and pharmaceutical business

California is now home to three biotech and pharmaceutical hubs, located in the Bay Area (San Francisco), San Diego, and now Los Angeles.

By GlobalData Healthcare

According to Biocom’s 2019 Economic Impact Report Databook, California is now home to three biotech and pharmaceutical hubs, located in the Bay Area (San Francisco), San Diego, and now Los Angeles. With this in mind, analysis can be completed in the Clinical Trials Database of GlobalData’s Pharma Intelligence Center to find more information and trends for the state of California.

Free Report
img

How is the Biopharmaceutical industry evolving?

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. Access the report to:
  • Benchmark the impact of major themes on the Biopharmaceutical industry.
  • Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents.
  • Evaluate the effects of COVID-19 on the sector.
Download the full report to understand what to expect and how to align your strategies for success.
by GlobalData
Enter your details here to receive your free Report.

Biopharma clusters

Looking at clinical trial sites in California, it can be seen that the three cities mentioned above are the top three cities for the clinical trial sites (Figure 1). Los Angeles had the most clinical trial sites in California with 11%, followed by San Francisco (6.4%) and San Diego (6.3%). Sacramento and Long Beach rounded out the top five.

Figure 2 shows the trends of clinical trials in California by city. Again, Los Angeles was the top city with 15.2% of all clinical trials in the state of California, San Francisco was second with 8.4% trials, and San Diego was third with 6.8% trials. Sacramento was again fourth with now Stanford rounding out the top five.

As for organisations in the state of California, the Stanford University School of Medicine has the most clinical trials with 2.6% of all clinical trials in the state of California. The University of California San Francisco followed with 2.4% while Kaiser Permanente, USC Norris Comprehensive Cancer Center, and Cedars-Sinai Medical Center all had under 2.0%. This can be seen in Figure 3.

Related Companies

Free Report
img

How is the Biopharmaceutical industry evolving?

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. Access the report to:
  • Benchmark the impact of major themes on the Biopharmaceutical industry.
  • Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents.
  • Evaluate the effects of COVID-19 on the sector.
Download the full report to understand what to expect and how to align your strategies for success.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology